C.M. Rodriguez‐Lopez

938 total citations
35 papers, 707 citations indexed

About

C.M. Rodriguez‐Lopez is a scholar working on Psychiatry and Mental health, Pharmacology and Neurology. According to data from OpenAlex, C.M. Rodriguez‐Lopez has authored 35 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Psychiatry and Mental health, 12 papers in Pharmacology and 4 papers in Neurology. Recurrent topics in C.M. Rodriguez‐Lopez's work include Fibromyalgia and Chronic Fatigue Syndrome Research (15 papers), Musculoskeletal pain and rehabilitation (8 papers) and Eating Disorders and Behaviors (3 papers). C.M. Rodriguez‐Lopez is often cited by papers focused on Fibromyalgia and Chronic Fatigue Syndrome Research (15 papers), Musculoskeletal pain and rehabilitation (8 papers) and Eating Disorders and Behaviors (3 papers). C.M. Rodriguez‐Lopez collaborates with scholars based in Spain, Argentina and Italy. C.M. Rodriguez‐Lopez's co-authors include Elena P. Calandre, Fernando Rico‐Villademoros, Juan M. Garcia‐Leiva, Rocío Molina-Barea, David A. Cano, Javier Luis López Hidalgo, Mahmoud Slim, Nicolás A. Núñez, Juan V. Luciano and Antoni Serrano‐Blanco and has published in prestigious journals such as Journal of Hepatology, Psychopharmacology and Pharmacological Research.

In The Last Decade

C.M. Rodriguez‐Lopez

33 papers receiving 681 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C.M. Rodriguez‐Lopez Spain 16 408 250 104 103 80 35 707
Danny Bega United States 17 293 0.7× 80 0.3× 43 0.4× 71 0.7× 85 1.1× 66 1.0k
Jo Ann T. Tschanz United States 9 401 1.0× 127 0.5× 34 0.3× 470 4.6× 51 0.6× 10 1.1k
Brigitte Vanle United States 11 95 0.2× 161 0.6× 30 0.3× 81 0.8× 57 0.7× 20 613
Sandra Vicari United States 14 238 0.6× 148 0.6× 226 2.2× 225 2.2× 76 0.9× 14 859
Chun-Hsin Chen Taiwan 24 430 1.1× 146 0.6× 41 0.4× 245 2.4× 73 0.9× 53 1.3k
Xavier Masramón Spain 15 321 0.8× 166 0.7× 111 1.1× 189 1.8× 98 1.2× 24 729
Jan Fawcett United States 13 234 0.6× 287 1.1× 34 0.3× 54 0.5× 62 0.8× 16 739
Maria Radziwoń-Zaleska Poland 12 118 0.3× 82 0.3× 125 1.2× 94 0.9× 32 0.4× 28 793
Maureen Kanzler United States 13 285 0.7× 245 1.0× 20 0.2× 154 1.5× 29 0.4× 19 616
Chay‐Hoon Tan Singapore 14 270 0.7× 55 0.2× 23 0.2× 83 0.8× 36 0.5× 24 592

Countries citing papers authored by C.M. Rodriguez‐Lopez

Since Specialization
Citations

This map shows the geographic impact of C.M. Rodriguez‐Lopez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.M. Rodriguez‐Lopez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.M. Rodriguez‐Lopez more than expected).

Fields of papers citing papers by C.M. Rodriguez‐Lopez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.M. Rodriguez‐Lopez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.M. Rodriguez‐Lopez. The network helps show where C.M. Rodriguez‐Lopez may publish in the future.

Co-authorship network of co-authors of C.M. Rodriguez‐Lopez

This figure shows the co-authorship network connecting the top 25 collaborators of C.M. Rodriguez‐Lopez. A scholar is included among the top collaborators of C.M. Rodriguez‐Lopez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.M. Rodriguez‐Lopez. C.M. Rodriguez‐Lopez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rodriguez‐Lopez, C.M., et al.. (2014). Trends in the dispensation of antidepressant drugs over the past decade (2000–2010) in Andalusia, Spain. Social Psychiatry and Psychiatric Epidemiology. 50(5). 705–712. 11 indexed citations
2.
3.
Slim, Mahmoud, Rocío Molina-Barea, Juan M. Garcia‐Leiva, et al.. (2014). The effects of gluten-free diet versus hypocaloric diet among patients with fibromyalgia experiencing gluten sensitivity symptoms: Protocol for a pilot, open-label, randomized clinical trial. Contemporary Clinical Trials. 40. 193–198. 10 indexed citations
4.
Rodriguez‐Lopez, C.M., et al.. (2012). Ozone Therapy as Add-On Treatment in Fibromyalgia Management by Rectal Insufflation: An Open-Label Pilot Study. The Journal of Alternative and Complementary Medicine. 19(3). 238–242. 21 indexed citations
5.
Calandre, Elena P., Fernando Rico‐Villademoros, & C.M. Rodriguez‐Lopez. (2012). Monotherapy or Combination Therapy for Fibromyalgia Treatment?. Current Rheumatology Reports. 14(6). 568–575. 19 indexed citations
6.
Rico‐Villademoros, Fernando, et al.. (2012). Amisulpride in the treatment of fibromyalgia: an uncontrolled study. Clinical Rheumatology. 31(9). 1371–1375. 3 indexed citations
7.
Calandre, Elena P., et al.. (2011). Trazodone plus pregabalin combination in the treatment of fibromyalgia: a two-phase, 24-week, open-label uncontrolled study. BMC Musculoskeletal Disorders. 12(1). 95–95. 35 indexed citations
8.
Rico‐Villademoros, Fernando, et al.. (2011). Sexual Functioning in Women and Men with Fibromyalgia. The Journal of Sexual Medicine. 9(2). 542–549. 27 indexed citations
9.
Calandre, Elena P., Rocío Molina-Barea, Juan M. Garcia‐Leiva, et al.. (2011). Suicide attempts and risk of suicide in patients with fibromyalgia: a survey in Spanish patients. Lara D. Veeken. 50(10). 1889–1893. 52 indexed citations
10.
Rodriguez‐Lopez, C.M., et al.. (2010). Trazodone for the treatment of fibromyalgia: an open-label, 12-week study. BMC Musculoskeletal Disorders. 11(1). 204–204. 30 indexed citations
11.
Calandre, Elena P., et al.. (2010). Pregabalin in the Treatment of Chronic Migraine. Clinical Neuropharmacology. 33(1). 35–39. 48 indexed citations
12.
Calandre, Elena P., et al.. (2007). Pregabalin Augmentation of Quetiapine Therapy in the Treatment of Fibromyalgia: An Open-Label, Prospective Trial. Pharmacopsychiatry. 40(2). 68–71. 24 indexed citations
13.
Olmos, Valentina, et al.. (2006). High-Performance Liquid Chromatography Method for Urinary trans, trans-Muconic Acid. Application to Environmental Exposure to Benzene. Journal of Analytical Toxicology. 30(4). 258–261. 10 indexed citations
14.
Calandre, Elena P., et al.. (2004). Peroxidación lipídica en pacientes epilépticos adultos tratados con ácido valproico. Revista de Neurología. 38(2). 101–101. 20 indexed citations
15.
Rodriguez‐Lopez, C.M., et al.. (2002). Alteration of biochemical parameters related with exposure to lead in heavy alcohol drinkers. Pharmacological Research. 45(1). 47–50. 7 indexed citations
16.
Rodriguez‐Lopez, C.M., et al.. (2001). Emergencia a la resistencia antibiótica en cepas de Campylobacter jejuni aisladas de carne de pollo. 1 indexed citations
17.
Rodriguez‐Lopez, C.M., et al.. (2000). Thyroid hormone changes in males exposed to lead in the buenos aires area (argentina). Pharmacological Research. 42(6). 599–602. 63 indexed citations
18.
Bergamaschi, S., F. Battaini, Marco Trabucchi, et al.. (1995). Neuronal differentiation modifies the effect of ethanol exposure on voltage-dependent calcium channels in NG 108-15 cells. Alcohol. 12(6). 497–503. 14 indexed citations
19.
Calandre, Elena P., et al.. (1991). Serum lipids, lipoproteins and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenobarbital. Acta Neurologica Scandinavica. 83(4). 250–253. 74 indexed citations
20.
Rodriguez‐Lopez, C.M., Marcello Diego Lograno, F. Battaini, et al.. (1990). Effect of chronic ethanol administration to adult or pregnant rats on phorbol ester binding in various brain areas. Pharmacological Research. 22. 55–56. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Danny Bega Breakdown of academic impact, for papers by Jo Ann T. Tschanz Breakdown of academic impact, for papers by Brigitte Vanle Breakdown of academic impact, for papers by Sandra Vicari Breakdown of academic impact, for papers by Chun-Hsin Chen Breakdown of academic impact, for papers by Xavier Masramón Breakdown of academic impact, for papers by Jan Fawcett Breakdown of academic impact, for papers by Maria Radziwoń-Zaleska Breakdown of academic impact, for papers by Maureen Kanzler Breakdown of academic impact, for papers by Chay‐Hoon Tan
Rankless by CCL
2026